We propose a comprehensive model where ketamine, and R,R-HNK, like fluoxetine, release TRKB from PTPσ restraining activity, resulting in visual cortex plasticity! 5/5
Very excited to share our recent preprint on ketamine and its active metabolite R,R-HNK action! Thank you to the co-authors Anna Rubiolo, @p_casarotto and @castren_eero for all their contributions!
https://t.co/jN29wm5TdU 1/5
We further show in vitro that these drugs disrupt the interaction between TRKB (the BDNF receptor) and PTPσ (receptor for PNNs), disinhibiting TRKB, as seen previously for fluoxetine. 4/5
https://t.co/jS3xMKtLDD
Here's the 2nd episode of our TSB-iCAN mini series! @DidioGiuliano & @tomasgarniera interview Prof @LeppaSM talking about cancer treatment🎗
On all podcasting platforms:
🍎 https://t.co/7JEIvySBJG
🟢 https://t.co/3qtr5mMJe1
☁ https://t.co/91MexXOVis
#CancerResearch#SciComm
What really is cancer? And importantly, can we defeat it? TSB & @iCAN_Finland are collaborating with a podcast mini series all about cancer & cancer research - listen to our first interview of the series with @tomakela today! 🎗
#CancerResearch#WorldCancerDay#SciComm#podcast
The miniseries tackles questions such as:
🎗️What would it take to beat cancer?
🎗️Why is the journey from labs to patients so long?
🎗️How is treatment taken to a very personal level?
🎗️How is artificial intelligence used in cancer?
🎗️How does the future of cancer research look?
Today, #WorldCancerDay, we start our new mini-series of 5 episodes in collab with @iCAN_Finland! In this first one, you'll find out about what is cancer, what do we know and what we still have to learn about it! #CancerResearch#scicomm
Ahead of #WorldCancerDay, we are excited to announce our upcoming #podcast miniseries about cancer research in collaboration with @ScienceBasement! The 1st episode of semi-serious conversations with iCAN scientists “Can we beat cancer?”@tomakela will be out on Friday, stay tuned!
Did you miss our latest podcast episode about psychedelics & brain plasticity ?
Here's where you can find it and chatch up!
Spotify 👉 https://t.co/X74mVycIGR
iTunes 👉 https://t.co/5UqXRpuOUa
SoundCloud 👉 https://t.co/FVD1tcZTNB
#SciComm#brain#science#depression@tttv2021
Join our **TSB Writing Workshop**!✒️For anyone interested in writing about science and research. ✒️Sessions have a short theory presentation and ‘pomodoro’-style writing session and peer feedback. ✒️Register here: https://t.co/rAeSJES6m5
#scicomm#scienceandresearch#TSB
The Symposium is only a week away!
We have more than 400 people registered around the world and there is still time to join us:
https://t.co/T7W2IIZY0R
#BMsymp2021#BiotechUH#HelsinkiHealth
Hey researcher at the University of Helsinki, what is your research all about?
Share it! Include hashtags #MinäTutkin (=I study) and #MyResearch. Tag us in it too. 💪 We will RT!
#WeAreHelsinkiUni
One example by Pedro. 👇
https://t.co/Rs8AMHBPlY
#Minätutkin how antidepressants or exercise make the adult brain plastic -aka flexible- again. This can lead to new drugs and treatment refinement for depression and other diseases.
#MyResearch#WeAreHelsinkiUni@helsinkiuni
"Science is therefore a continually dynamic and evolving conversation about how the world works... Involving/engaging the public in this conversation is of utmost importance to maintain the trust in the scientific method and in the scientific community".
#scicomm
Can we talk about #reproducibility to general public? How about using a cartoon? @ThisIsSaraJager and @katjaviivi show us 'YES, WE CAN'. New commentary on JRepNeurosci about communicating reproducibility to public, with a cool cartoon 😉
https://t.co/3f6OjVPzKx